Pfaffenseller, B
da Silva Magalhães, P V
De Bastiani, M A
Castro, M A A
Gallitano, A L
Kapczinski, F
Klamt, F
Article History
Received: 16 March 2016
Accepted: 23 March 2016
First Online: 10 May 2016
Competing interests
: Professor Kapczinski has received grant/research support from Astra-Zeneca, Eli Lilly, the Janssen-Cilag, Servier, CNPq, CAPES, NARSAD and the Stanley Medical Research Institute; has been a member of the speakers’ boards for Astra-Zeneca, Eli Lilly, Janssen and Servier; and has served as a consultant for Servier. The remaining authors declare no conflict of interest.